Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER

计划入组 20 人 · 首次发布于 2005 年 9 月 21 日

First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation

计划入组 10 人 · 首次发布于 2026 年 4 月 17 日

Tisento Therapeutics Inc.

United States

University of Trento

Italy

AZIENDA PROVINCIALE PER I SERVIZI SANITARI DELLA PROVINCIA AUTONOMA DI TRENTO

Italy

Tisento Therapeutics Receives FDA Fast Track Designation for Zagociguat in MELAS Treatment

Tisento Therapeutics Doses First Participant in Phase 2b Trial of Zagociguat for MELAS

Cyclerion Therapeutics Pivots to Neuropsychiatry with MIT-Licensed Treatment-Resistant Depression Program